THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Elizabeth Hile

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
3
2024
769
1.000
 Why?
Diabetic Neuropathies
1
2024
14
0.890
 Why?
Hallux
1
2023
3
0.850
 Why?
Athletic Performance
1
2023
46
0.830
 Why?
Sarcopenia
1
2022
42
0.750
 Why?
Resistance Training
1
2022
209
0.650
 Why?
Gait
4
2012
58
0.600
 Why?
Postural Balance
3
2012
38
0.580
 Why?
Disability Evaluation
4
2012
54
0.530
 Why?
Geriatric Assessment
3
2012
86
0.490
 Why?
Gait Disorders, Neurologic
1
2010
6
0.350
 Why?
Peripheral Nervous System Diseases
1
2010
17
0.350
 Why?
Antineoplastic Agents, Phytogenic
1
2010
53
0.340
 Why?
Aged
9
2023
5232
0.330
 Why?
Exercise Therapy
2
2022
80
0.330
 Why?
Paclitaxel
1
2010
184
0.320
 Why?
Female
10
2024
14658
0.250
 Why?
Humans
12
2024
27175
0.230
 Why?
Breast
1
2024
54
0.220
 Why?
Toes
1
2023
3
0.210
 Why?
Artificial Intelligence
1
2024
45
0.210
 Why?
Mobility Limitation
3
2011
14
0.200
 Why?
Lower Extremity
1
2023
84
0.200
 Why?
Longevity
1
2023
129
0.190
 Why?
Preoperative Care
1
2022
76
0.190
 Why?
Motor Activity
2
2013
145
0.180
 Why?
Muscle Strength
1
2022
228
0.170
 Why?
Cancer Survivors
1
2020
38
0.160
 Why?
Activities of Daily Living
1
2020
101
0.160
 Why?
Male
8
2023
13034
0.160
 Why?
Injections, Epidural
1
2019
3
0.160
 Why?
Conservative Treatment
1
2019
10
0.160
 Why?
Musculoskeletal Manipulations
1
2019
5
0.160
 Why?
Spinal Stenosis
1
2019
15
0.160
 Why?
Medication Therapy Management
1
2019
18
0.150
 Why?
Quality of Life
2
2020
467
0.150
 Why?
Lumbar Vertebrae
1
2019
123
0.140
 Why?
Cross-Sectional Studies
4
2013
936
0.130
 Why?
Aging
1
2024
960
0.130
 Why?
Accidental Falls
2
2013
31
0.130
 Why?
Fear
2
2013
58
0.130
 Why?
Young Adult
1
2023
2636
0.130
 Why?
Surveys and Questionnaires
3
2013
932
0.110
 Why?
Walking
2
2011
130
0.110
 Why?
Body Mass Index
2
2011
385
0.100
 Why?
Data Interpretation, Statistical
1
2012
56
0.100
 Why?
Aged, 80 and over
3
2011
1943
0.090
 Why?
Psychometrics
1
2011
118
0.090
 Why?
Adult
1
2023
7510
0.090
 Why?
Dancing
1
2010
13
0.090
 Why?
Video Games
1
2010
20
0.090
 Why?
Mastectomy
1
2010
21
0.090
 Why?
Exercise Test
1
2011
248
0.090
 Why?
Health Promotion
1
2010
171
0.080
 Why?
Middle Aged
3
2019
6918
0.070
 Why?
Breast Neoplasms
1
2010
447
0.060
 Why?
Linear Models
2
2013
202
0.050
 Why?
Self Report
2
2013
116
0.050
 Why?
Analysis of Variance
2
2011
388
0.040
 Why?
Health Surveys
1
2020
78
0.040
 Why?
Ambulatory Care Facilities
1
2019
52
0.040
 Why?
Age Factors
1
2020
724
0.040
 Why?
Tomography, X-Ray Computed
1
2019
467
0.030
 Why?
Magnetic Resonance Imaging
1
2019
811
0.030
 Why?
Treatment Outcome
1
2020
2289
0.030
 Why?
Accelerometry
1
2013
11
0.030
 Why?
Task Performance and Analysis
1
2011
42
0.020
 Why?
Observation
1
2011
5
0.020
 Why?
Self Disclosure
1
2011
5
0.020
 Why?
Chi-Square Distribution
1
2011
144
0.020
 Why?
Self Efficacy
1
2011
73
0.020
 Why?
Housing for the Elderly
1
2010
2
0.020
 Why?
Social Participation
1
2010
3
0.020
 Why?
Patient Compliance
1
2010
75
0.020
 Why?
Comorbidity
1
2011
249
0.020
 Why?
Predictive Value of Tests
1
2011
472
0.020
 Why?
Feasibility Studies
1
2010
191
0.020
 Why?
Health Status
1
2010
146
0.020
 Why?
Reproducibility of Results
1
2011
752
0.020
 Why?
Prospective Studies
1
2011
1224
0.020
 Why?
Hile's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Co-Authors (1)
Explore
_
Similar People (56)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES